Mitchell Levine
2019
In 2019, Mitchell Levine earned a total compensation of $1.2M as Chief Financial Officer at Oncocyte Corp, a 33% increase compared to previous year.
Compensation breakdown
| Bonus | $131,670 |
|---|---|
| Option Awards | $600,142 |
| Salary | $343,063 |
| Stock Awards | $70,400 |
| Other | $12,662 |
| Total | $1,157,937 |
Levine received $600.1K in option awards, accounting for 52% of the total pay in 2019.
Levine also received $131.7K in bonus, $343.1K in salary, $70.4K in stock awards and $12.7K in other compensation.
Rankings
In 2019, Mitchell Levine's compensation ranked 8,599th out of 13,971 executives tracked by ExecPay. In other words, Levine earned more than 38.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,599 out of 13,971 | 39th |
Division Manufacturing | 3,412 out of 5,692 | 40th |
Major group Chemicals And Allied Products | 1,292 out of 2,189 | 41st |
Industry group Drugs | 1,099 out of 1,875 | 41st |
Industry In Vitro and In Vivo Diagnostic Substances | 32 out of 77 | 58th |
Source: SEC filing on May 26, 2020.
Levine's colleagues
We found five more compensation records of executives who worked with Mitchell Levine at Oncocyte Corp in 2019.
2019
Ronald Andrews
Oncocyte Corp
Chief Executive Officer
2019
William Annett
Oncocyte Corp
Chief Executive Officer
2019
Lyndal Hesterberg
Oncocyte Corp
Chief Scientific Officer
2019
Albert Parker
Oncocyte Corp
Chief Operating Officer
2019
Padma Sundar
Oncocyte Corp